China is forging ahead to conduct human clinical trials of treatments using the CRISPR gene-editing tool, the Wall Street Journal reports. The first CRISPR trial began in China in 2015, while the first outside of China, likely to be at the University of Pennsylvania, has yet to begin, it adds.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.
60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.
In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.
Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.